| Literature DB >> 22899957 |
Jintanaporn Wattanathorn1, Supaporn Muchimapura, Terdthai Tong-Un, Narisara Saenghong, Wipawee Thukhum-Mee, Bungorn Sripanidkulchai.
Abstract
Health-related physical fitness declines as the age advances. Oxidative stress is reported to contribute the crucial role on this phenomenon. This condition is also enhanced by antioxidant. Therefore, we aimed to determine the effect of Kaempferia parviflora, a plant reputed for antifatigue, longevity promotion, and antioxidant effects, on health-related quality physical fitness and oxidative status of the healthy elderly volunteers. Total 45 subjects had been randomized to receive placebo or K. parviflora extract at doses of 25 or 90 mg once daily for 8 weeks. They were determined baseline data of physical performance using 30 sec chair stand test, hand grip test, 6 min walk test, and tandem test. Serum oxidative stress markers including malondialdehde (MDA) level and the activities of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) were also assayed. All assessments were performed every 4 weeks throughout the 8-week study period. The results showed that K. parviflora increased performance in 30-second chair stand test and 6 min walk test together with the increased all scavenger enzymes activities and the decreased MDA level. Therefore, K. parviflora can enhance physical fitness partly via the decreased oxidative stress. In conclusion, K. parviflora is the potential health supplement for elderly. However, further study is required.Entities:
Year: 2012 PMID: 22899957 PMCID: PMC3415259 DOI: 10.1155/2012/732816
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Demographic data of subjects (n = 15/group).
| General characteristic | Placebo | KP25 | KP90 |
|---|---|---|---|
| 62.66 ± 6.33 | |||
| Age (years) | 64.2 ± 6.95 | 61.53 ± 6.39 |
|
|
| |||
|
| |||
| 7.33 ± 2.96 | |||
| Education (years) | 7.73 ± 2.65 | 7.53 ± 2.82 |
|
|
| |||
|
| |||
| 91.26 ± 4.31 | |||
| Full-scale IQ | 90.6 ± 7.66 | 89.2 ± 63.55 |
|
|
| |||
|
| |||
| 120.20 ± 5.94 | |||
| Systolic blood pressure (mmHg) | 122.26 ± 8.22 | 121.20 ± 6.63 |
|
|
| |||
|
| |||
| 84.80 ± 6.47 | |||
| Diastolic blood pressure (mmHg) | 81.53 ± 6.84 | 83.26 ± 7.64 |
|
|
| |||
|
| |||
| 23.04 ± 1.67 | |||
| Body mass index | 21.92 ± 2.06 | 23.27 ± 1.34 |
|
|
| |||
Data were present as mean ± SEM.
Effect of various doses of K. parviflora on health related physical fitness.
| Measured parameters | Group | Pre-dose | 1 month | 2 month |
|---|---|---|---|---|
| Placebo | 24.53 + 2.55 | 24.33 + 2.28 | 24.33 + 2.46 | |
| Grip strength (Rt) (kg) | KP25 | 25.06 + 3.01 | 25 + 2.97 | 24.86 + 3.18 |
| KP90 | 23.93 + 3.30 | 24.6 + 3.13 | 24.8 + 3.14 | |
|
| ||||
| Placebo | 21.06 + 1.83 | 21.33 + 1.58 | 21.2 + 1.56 | |
| Grip strength (Lt) (kg) | KP25 | 22.06 + 1.86 | 21.66 + 1.5 | 21.26 + 1.48 |
| KP90 | 20.86 + 2.72 | 21.6 + 2.02 | 21.6 + 1.84 | |
|
| ||||
| Placebo | 19.13 + 2.79 | 19.26 + 1.43 | 18.93 + 1.70 | |
| 30-second chair stand test. (sec) | KP25 | 18.33 + 2.58 | 19 + 2.77 | 20 + 3.11 |
| KP90 | 18.6 + 2.52 | 19.6 + 2.13 | 20.66 + 2.28# | |
|
| ||||
| Placebo | 567.33 + 33.52 | 598.73 + 31.57 | 571.26 + 32.05 | |
| 6 min. walk test (m.) | KP25 | 571.26 + 33.68 | 570.33 + 38.32 | 575.53 + 36.04 |
| KP90 | 572.8 + 32.65 | 575.46 + 34.29 | 601.26 + 33.70∗# | |
|
| ||||
| Placebo | 164.8 ± 12.34 | 163.06 ± 10.35 | 165.06 ± 9.80 | |
| Tandem test (Opened Eye, Right leg is in front) (sec) | KP25 | 161.8 ± 11.16 | 164.06 ± 9.63 | 162.26 ± 8.93 |
| KP90 | 164 ± 10.50 | 166.6 ± 6.81 | 168.46 + 6.90 | |
|
| ||||
| Placebo | 112.33 ± 11.00 | 110.66 ± 10.01 | 109 + 10.20 | |
| Tandem test (Opened Eye, Left leg is in front) (sec) | KP25 | 111.93 ± 7.77 | 112.33 ± 11.39 | 111.8 + 10.16 |
| KP90 | 108.2 ± 11.32 | 109.33 ± 13.62 | 110.46 + 13.31 | |
|
| ||||
| Placebo | 33.8 ± 9.22 | 30.8 ± 10.74 | 31.66 + 10.41 | |
| Tandem test (Closed Eye, Right leg is in front) (sec) | KP25 | 31.86 ± 10.12 | 32.6 ± 7.44 | 32.73 + 7.67 |
| KP90 | 31.26 ± 11.09 | 31.86 ± 9.33 | 33.4 + 8.94 | |
|
| ||||
| Placebo | 18.8 + 3.60 | 19.86 + 5.01 | 21.2 + 4.57 | |
| Tandem test (Closed Eye, Left leg is in front) (sec) | KP25 | 20.93 + 3.41 | 21.33 + 3.79 | 21.26 + 3.19 |
| KP90 | 20.46 + 4.24 | 21.26 + 4.58 | 22.06 + 3.93 | |
Data were present as mean ± SEM (n = 15/group).
*P value <0.05 compared to placebo, # P value <0.05 compared to baseline.
Figure 1Effect of various doses of K. parviflora on level of superoxide dismutase in serum. Data were present as mean ± SEM (n = 15/group). ∗∗,∗∗∗ P value <0.01; 0.001 compared with placebo group, respectively. #,### P value <0.05; 0.01 compared to baseline, respectively.
Figure 4Effect of various doses of K. parviflora on level of malondialdehyde (MDA) in serum. Data were present as mean ± SEM (n = 15/group). **P value <0.01 compared with placebo group. # P value <0.05 compared to baseline.
Figure 5Schematic diagram illustrated the possible action of K. parviflora on muscle strength of lower extremities and aerobic endurance.